Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Return on Tangible Equity 2017-2025 | ORINY

Current and historical return on tangible equity values for Orion OYJ (ORINY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Orion OYJ Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $0.41B $0.83B 47.79%
2025-03-31 $0.38B $0.94B 46.51%
2024-12-31 $0.36B $0.90B 50.46%
2024-09-30 $0.36B $0.79B 53.89%
2024-06-30 $0.25B $0.60B 38.77%
2024-03-31 $0.24B $0.55B 35.92%
2023-12-31 $0.24B $0.75B 35.42%
2023-09-30 $0.19B $0.70B 28.84%
2023-06-30 $0.32B $0.63B 46.09%
2023-03-31 $0.35B $0.58B 50.23%
2022-12-31 $0.37B $0.76B 51.50%
2022-09-30 $0.37B $0.82B 50.40%
2022-06-30 $0.22B $0.64B 31.18%
2022-03-31 $0.22B $0.64B 29.23%
2021-12-31 $0.23B $0.80B 29.65%
2021-09-30 $0.23B $0.79B 29.56%
2021-06-30 $0.23B $0.79B 29.86%
2021-03-31 $0.25B $0.71B 32.49%
2020-12-31 $0.25B $0.79B 31.01%
2020-09-30 $0.27B $0.84B 32.68%
2020-06-30 $0.29B $0.73B 36.38%
2020-03-31 $0.25B $0.88B 32.51%
2019-12-31 $0.23B $0.82B 31.91%
2019-09-30 $0.23B $0.73B 32.93%
2019-06-30 $0.19B $0.65B 26.58%
2019-03-31 $0.37B $0.62B 48.33%
2018-12-31 $0.39B $0.84B 51.71%
2018-09-30 $0.40B $0.81B 55.12%
2018-06-30 $0.41B $0.79B 60.41%
2018-03-31 $0.25B $0.58B 40.63%
2017-12-31 $0.26B $0.71B 43.45%
2017-09-30 $0.24B $0.64B 41.78%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.848B $1.669B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.033B 26.94
Zoetis (ZTS) United States $68.299B 24.78
Takeda Pharmaceutical (TAK) Japan $47.729B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.567B 24.38
BeOne Medicines - (ONC) Switzerland $35.221B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.101B 0.00
Summit Therapeutics (SMMT) United States $19.827B 0.00
Merck (MKKGY) Germany $17.079B 11.11
Shionogi (SGIOY) Japan $15.193B 15.22
United Therapeutics (UTHR) United States $14.124B 12.22
Neurocrine Biosciences (NBIX) United States $13.181B 39.32
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.212B 0.00
Corcept Therapeutics (CORT) United States $7.560B 63.49
Grifols, S.A (GRFS) Spain $7.371B 0.00
Ionis Pharmaceuticals (IONS) United States $6.978B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $3.807B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.968B 14.10
Crinetics Pharmaceuticals (CRNX) United States $2.893B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.815B 0.00
Hypermarcas (HYPMY) Brazil $2.676B 20.12
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.420B 0.00
Ocular Therapeutix (OCUL) United States $2.196B 0.00
Dyne Therapeutics (DYN) United States $1.761B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.757B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Guardian Pharmacy Services (GRDN) United States $1.495B 0.00
Ardelyx (ARDX) United States $1.439B 0.00
Harrow (HROW) United States $1.436B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.329B 0.00
Xeris Biopharma Holdings (XERS) United States $1.240B 0.00
Enliven Therapeutics (ELVN) United States $1.198B 0.00
Collegium Pharmaceutical (COLL) United States $1.189B 6.50
Cronos Group (CRON) Canada $0.908B 0.00
Akebia Therapeutics (AKBA) United States $0.862B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.713B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.709B 7.30
ProKidney (PROK) United States $0.691B 0.00
Theravance Biopharma (TBPH) United States $0.662B 54.79
KalVista Pharmaceuticals (KALV) United States $0.643B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
Bioventus (BVS) United States $0.609B 14.74
Siga Technologies (SIGA) United States $0.609B 7.52
Organogenesis (ORGO) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.580B 0.00
Oruka Therapeutics (ORKA) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.39
Xencor (XNCR) United States $0.548B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.518B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.450B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.379B 0.00
4D Molecular Therapeutics (FDMT) United States $0.339B 0.00
Larimar Therapeutics (LRMR) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Altimmune (ALT) United States $0.320B 0.00
AleAnna (ANNA) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.01
OmniAb (OABI) United States $0.245B 0.00
Galectin Therapeutics (GALT) United States $0.226B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.203B 0.00
Aclaris Therapeutics (ACRS) United States $0.203B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Korro Bio (KRRO) United States $0.190B 0.00
China SXT Pharmaceuticals (SXTC) China $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.167B 25.75
Journey Medical (DERM) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.104B 0.00
Dominari Holdings (DOMH) United States $0.098B 0.00
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.086B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Wellgistics Health (WGRX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 28.45
Tempest Therapeutics (TPST) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Mural Oncology (MURA) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.02
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00